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Two studies by Sakurai et al. (2014) and Hu et al. (2014) in this issue of Cell Stem Cell add a new level of
understanding to the mesenchymal-to-epithelial transition taking place during reprogramming, showing
how this morphological transformation is promoted by Tet enzymes and blocked by kinase-dependent cyto-
skeletal organization.The groundbreaking discovery that so-
matic cells can be reprogrammed to
induced pluripotent stem cells (iPSCs)
by transgene expression of the transcrip-
tion factors Oct4, Sox2, Klf4, and Myc
(OSKM) has generated a new boundless
perception of cell fate and raises hopes
for regenerative medicine (Yamanaka,
2012). Reprogramming fibroblasts with
OSKM occurs through the timely acquisi-
tion of molecular and cellular changes as
somatic cells gradually become pluripo-
tent. These events can be grouped into
three phases, which include (1) initiation,
where cells lose their somatic program,
change metabolism and increase prolif-
eration; (2) maturation, where cells start
to express the first pluripotency regula-
tors; and (3) stabilization, where cells
become self-renewing, express the full
complement of endogenous pluripotent
genes, reactivate their inactive X chro-
mosome, and restore telomere elonga-
tion (Figure 1) (David and Polo, 2014).
A key feature of the initiation phase is
a BMP-driven MET, which induces a
dramatic morphological change, turning
fibroblasts into epithelial-like cells (David
and Polo, 2014). During MET, the actin
cytoskeleton is reorganized from actin
stress fibers to cortical actin, expression
of mesenchymal transcription factors
such as Zeb1 and Snai1 is lost, and
cells establish tight and adherens junc-
tions stabilized by Par3/ZO-1 or E-Cad-
herin, respectively (Lamouille et al.,
2014). In this issue of Cell Stem Cell, Hu
et al. (2014) now uncover a new aspect
of how MET is epigenetically regulated,
while Sakurai et al. (2014) revealthe impact of novel kinases on actin
reorganization underlying MET during
reprogramming.
Changes in gene expression are largely
impacted by the epigenetic landscape,
including DNA methylation and histone
modifications. In order for endogenous
pluripotency genes to be activated during
reprogramming, they must be demethy-
lated. The ten-eleven translocation (Tet)
proteins are DNA hydroxylases that
mediate oxidation of methylcytosines,
and they have been implicated in reprog-
ramming for their ability to induceDNA hy-
droxymethylation and gene activation at
pluripotency genes such asNanog, Essrb,
and Oct4 (reviewed in Bagci and Fisher,
2013). However, it is not known whether
Tet enzymes (Tet1–3) are essential for re-
programming and whether they function
by facilitating active and/or passive DNA
demethylation of pluripotent loci (Bagci
and Fisher, 2013). Indeed, while the
involvement of individual Tets has been
studied by multiple groups, the potential
redundancy of these factors has not
been investigated in somatic cell reprog-
ramming. To circumvent this issue, Hu
et al. reprogrammed various combina-
tions of double (DKO) and triple (TKO)
Tet1–3 knockout cells with both constitu-
tive and conditional deletions (Hu et al.,
2014). This approach allowed them to
study the temporal role of the various
Tet enzymes during reprogramming.
Strikingly, Tet TKO ESCs displayed
a normal morphology, while Tet TKO
MEFs were completely impaired in their
ability to undergo reprogramming. Tet
TKO MEFs were specifically compro-Cell Stem Cemised during the initiation phase of re-
programming and not later phases.
Furthermore, Tet TKO MEFs were resis-
tant to MET. Building on these observa-
tions, Hu et al. elegantly showed that
while Tet TKO MEFs were compromised
in their ability to reprogram, Tet TKO
epithelial cells (keratinocytes and neural
progenitor cells) did not display even a
minor defect in reprogramming. Collec-
tively, this work indicates that Tet proteins
are vital regulators of MET and implies a
nonessential role for Tets in pluripotency
gene activation during reprogramming.
To further define the relationship be-
tween Tets and MET, Hu et al. focused
on the miR-200 family, previously shown
to promote MET during reprogramming
(Samavarchi-Tehrani et al., 2010). They
uncovered that Tet proteins mediate
DNA hydroxymethylation of the MET-
associated miR-200 clusters in MEFs
undergoing reprogramming. Moreover, a
similar phenotype was observed during
reprogramming of TDG KO MEFs,
showing that TDG, a DNA glycosylase
involved in active DNA demethylation, is
an important partner of Tets, essential to
stimulate expression of miR-200 miRNAs
during MET. These studies further
showed that the reprogramming defect
in Tet TKO MEFs as well as that of TDG
KOMEFs were partially rescued by trans-
fection of individual miRNAs from the
miR-200 family. This highlights the impact
of Tets via TDG to promote active DNA
demethylation and hence activation of
miR-200 clusters for MET in reprogram-
ming, supporting the importance of tar-
geted Tet activity rather than a broadll 14, April 3, 2014 ª2014 Elsevier Inc. 417
Figure 1. Regulation of the Mesenchymal-to-Epithelial Transition
during the Initiation Phase of Reprogramming
MET takes place during the initiation phase of reprogramming, followed by the
maturation and stabilization phases. M, Myc; K, Klf4. The question mark illus-
trates the potential for a yet unidentified epithelial master regulator driving
the MET.
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sine levels (Bagci and Fisher,
2013).
Poor reprogramming effi-
ciencies present a major
hurdle to iPSC research;
thus, developing strategies
to improve iPSC generation
is a primary goal. To identify
kinases that inhibit reprog-
ramming, Sakurai et al. per-
formed an shRNA screen
targeting the Kinome (Sakurai
et al. 2014). This approach is
quite original, as most of thepreviously reported screens were de-
signed to find essential regulators of
reprogramming, not barriers (Golipour
et al., 2012; Onder et al., 2012; Sama-
varchi-Tehrani et al., 2010). Among
the barrier-kinases identified, Tesk1 and
Limk2 knockdowns (KD), two kinases
linked to the integrin signaling network,
led to an increase in reprogramming effi-
ciency. KD of Tesk1 and Limk2 decreased
phosphorylation levels of the actin binding
protein Cofilin, hence destabilizing the
actin cytoskeleton of MEFs and ultimately
enhancing reprogramming. Furthermore,
Sakurai et al. translated these findings to
humans, showing that KD of TESK1 in
human fibroblasts similarly improved re-
programming efficiency. Reorganization
of the actin cytoskeleton is an unappreci-
ated but necessary step in MET. The work
by Sakurai et al. provides the description
of regulators that mediate this process
during reprogramming and highlights an
alternate way to enhance reprogramming
without stimulating major changes in
proliferation or stability of the genome.
While reprogramming is largely thought
to be driven by rewiring the transcrip-
tome, the findings by Sakurai et al.
suggest that signals linked to cell shape
are sufficient to interfere with reprogram-
ming. This observation echoes a recent
paper showing that specific micropat-
terns stimulate reprogramming in fibro-418 Cell Stem Cell 14, April 3, 2014 ª2014 Elblasts (Downing et al., 2013). In this study,
the authors forced cells to adhere to
different bioengineered substrates and
observed that distinct substrates trig-
gered epigenetic changes in histone acet-
ylation and methylation depending on the
biophysical environment (Downing et al.,
2013), showing remarkable regulation of
cell fate by the direct physical environ-
ment of cells.
The articles by Sakurai et al. and Hu
et al. describe two key mechanisms that
mediate MET as a necessary initial step
toward reprogramming. Previous studies
showed that MET is regulated by BMP
signaling and largely due to Myc silencing
of the fibroblast program, with activation
of the epithelial program regulated by
Klf4 (Figure 1) (David and Polo, 2014).
Now the challenge is to put all the
pieces of the puzzle together to unveil
precisely how MET is coordinated. Some
key questions that will need to be
addressed include whether OSK and/or
M directly regulate the expression of
Tets, TDG, Tesk1, and Limk2, and how
mesenchymal and/or epithelial reporter
genes would behave in Tet and TDG KO
MEFs during reprogramming. Finally,
there is no clear master transcription fac-
tor or factors that have been identified as
major drivers of MET during reprogram-
ming (Figure 1). A better understanding
of these issues could help us model asevier Inc.more linear sequence of
events and clarify our picture
of the dynamic interplay
that exists between signaling
pathways, transcriptional re-
gulation, epigenetic contri-
bution, and cell shape to
mediate MET in somatic cell
reprogramming.
Further elucidation of the
mechanisms of reprogram-
ming may make this process
more efficient and easily
reproducible for novel regen-
erative medicine approaches.On a larger scale, uncovering these
events in reprogrammingwill undoubtedly
provide additional insight toward regula-
tion of EMT in tumorigenesis.
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